Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-17-063987

Options or other derivatives

  • Director acquired 16,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BONNEY MICHAEL W · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-12-04 Grant or award : show line 1 in the form Non-Qualified Stock Options (right to buy) +16,400 $54.29 2027-12-04 16,400 16,400 D
Loading xslF345X03/doc4.xml…